About Us
Electro-Cyclonic Innovation LLC (ECI) was founded in Phoenix, Arizona on April 3, 2026, to develop and commercialize a fundamentally new approach to industrial wastewater treatment. ECI is the developer and owner of the Cyclonic Flow-Through Electrocoagulation (CFEC) reactor — a fully patented (US Patent No. 10,287,189 B2) technology that solves the passivation problem that has limited conventional electrocoagulation for decades. ECI's technology is currently the subject of sponsored research at Arizona State University, validating its performance across real-world industrial applications. ECI is led by Marc Tedhams, Technical Director and Sole Inventor of the CFEC Reactor, and is backed by experienced investors committed to bringing this technology to market.
ECI is backed by Wallace Olsen Jr., Managing Director, and Eric Olsen, Founder, Fasturtle, Marketing Advisor, whose combined experience across industry, business development, and marketing supports the company’s commercialization strategy. Website design and development by Fasturtle Interactive, Phoenix, Arizona.
Services
ECI's core service is the licensing and deployment of its proprietary Cyclonic Flow-Through Electrocoagulation (CFEC) reactor technology for industrial wastewater pretreatment.
Unlike conventional plate electrocoagulation systems — which progressively coat their electrodes with scale and require acid-soak maintenance, process interruption, and significant labor — the CFEC reactor operates continuously. Its cyclonic flow carries scale away from the electrode surfaces in-situ, eliminating the passivation problem that has made conventional EC self-defeating in sustained industrial use.
ECI offers:
Technology licensing to industrial equipment manufacturers and wastewater solution providers. Application consulting for facilities requiring removal of dissolved contaminants, heavy metals, fluoride, silica, and other contaminants. Research and development partnerships with industrial clients and academic institutions seeking validated electrocoagulation performance data.
Target industries include: semiconductor manufacturing, food and beverage processing, mining, mineral extraction, acid mine drainage, metal finishing, and municipal pretreatment facilities.
